Rhinitis Clinical Trial
Official title:
Evaluating the Need for a New Combination Nasal Spray in the Treatment of Seasonal Rhinitis
The proposed study will evaluate the unmet therapy need in seasonal rhinitis by aiming to
answer the following research questions
1. What is the first prescription of the hay-fever season and how many of these patients
are on some form of combination therapy?
2. To what extent does initial therapy not meet clinical need (as measured by need for
additional medical intervention in terms of consultations and changes in therapy)?
3. Does treatment for allergic rhinitis differ for asthma Vs non-asthma and seasonal Vs
perennial patients?
Allergic rhinitis is a chronic respiratory disease with a major impact on quality of life.
In a study looking at the burden of allergic rhinitis amongst UK patients 75% reported some
impact of their allergic rhinitis symptoms on health-related quality of life. Allergic
rhinitis currently affects 10-30% of the world population with prevalence and impact
continuing to increase. This leads to substantial economic costs both of prescription
medication and time taken off work by both patients and carers due to the disease. In view
of this, there may be a substantial need for improved therapy or management to ensure that
patients with allergic rhinitis can carry out a normal lifestyle.
The proposed study will evaluate the unmet therapy need in seasonal rhinitis by examining
the current medication requirements of patients who suffer from seasonal grass-pollen hay
fever and determining whether current therapies are sufficient for managing rhinitis.
This study aims to evaluate the unmet therapy need in seasonal rhinitis by -
1. Examining and describing current medication requirements
2. Quantifying the extent of co-prescribing of multiple agents
3. Comparing the effectiveness of current prescription drugs for managing and controlling
patient's seasonal rhinitis and using changes in treatment during the hay fever season
to determine the effectiveness of current therapy options.
for managing and controlling seasonal rhinitis in primary care patients who suffer from
seasonal grass-pollen hay fever.
;
Observational Model: Cohort, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02360072 -
Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma
|
||
Completed |
NCT02340130 -
Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma
|
Phase 2 | |
Completed |
NCT01118312 -
Study of Asthma and Nasal Steroids
|
Phase 4 | |
Completed |
NCT00762567 -
Phenylephrine Pediatric Pharmacokinetic Study
|
Phase 1 | |
Completed |
NCT00541255 -
A Long-Term Examination of Asthma From Childhood Through Adolescence
|
||
Completed |
NCT00279916 -
Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays
|
Phase 3 | |
Completed |
NCT00963573 -
Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428)
|
Phase 4 | |
Completed |
NCT00524836 -
Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic Rhinitis
|
Phase 3 | |
Completed |
NCT00521131 -
Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites
|
Phase 4 | |
Completed |
NCT04132570 -
A Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne Pollution
|
Phase 4 | |
Completed |
NCT02784262 -
Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis
|
Phase 2 | |
Completed |
NCT02596321 -
A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma
|
Phase 3 | |
Terminated |
NCT02630472 -
Topical Irrigation Therapy for CRS
|
Phase 1/Phase 2 | |
Completed |
NCT02279706 -
Korean Linguistic Adaptation of Rhinitis Controlled Assessment Test
|
N/A | |
Completed |
NCT01971086 -
Treatment With Rhinospray Plus in Patients With Acute Rhinitis in the Everyday Curative Routine in Hungary
|
N/A | |
Completed |
NCT01771120 -
Control and Burden of Asthma and Rhinitis
|
N/A | |
Completed |
NCT01469234 -
A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712)
|
Phase 4 | |
Withdrawn |
NCT01177852 -
Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute Rhinitis
|
Phase 3 | |
Completed |
NCT02879929 -
Development and Validity of the DyNaChron Questionnaire for Chronic Nasal Dysfunction
|
N/A | |
Completed |
NCT00724698 -
Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria
|